Film-shaped, orally-administered drug containing estriol
DE10354893A1
Use of deoxypeganine for the treatment of schizophrenic psychoses
DE10354894A1
Oral formulations of deoxypeganine and their applications
NZ538208A
Medicament for treating alcohol and/or tobacco addiction craving
DE10318714A1
Drug combinations and therapies to combat alcohol abuse
DE10304141A1
Process for the preparation of quinazoline alkaloids
DE10235556A1
Medicament for treating substance cravings, especially alcohol and/or tobacco abuse, comprising separate dosage forms for continuous release of nicotinic receptor modulator and rapid delivery of galanthamine
DE10163667A1
Use of deoxypeganine for the treatment of clinical depression
DE10157745A1
Transdermal therapeutic system for the administration of 17alpha-estradiol
DE10134038A1
Active ingredient combination for drug therapy of nicotine addiction
DE10129265A1
Active ingredient combination for drug addiction or intoxicant therapy
DE10119863A1
Use of deoxypeganine for the treatment of psychiatric or cerebral symptoms
DE10119862A1
Use of galanthamine for the treatment of symptoms of the central nervous system due to intoxications with psychotropic substances
DE4139114A1
Use of monoesters from glucocorticoids and organic acids for the delayed treatment of diseases treatable with glucocorticoids in human medicine
